Stem cell activation sustains hereditary hypertrophy in hamster cardiomyopathy

被引:23
作者
Fiaccavento, R
Carotenuto, F
Minieri, M
Fantini, C
Forte, G
Carbone, A
Carosella, L
Bei, R
Masuelli, L
Palumbo, C
Modesti, A
Prat, M
Di Nardo, P
机构
[1] Univ Roma Tor Vergata, Dipartimento Med Interna, Lab Cardiol Mol & Cellulare, I-00133 Rome, Italy
[2] Univ Roma Tor Vergata, Dipartimento Med Sperimentale & Sci Biochim, I-00133 Rome, Italy
[3] Syntech Srl, Rome, Italy
[4] Univ Cattolica Sacro Cuore, Ist Anat Patol, I-00168 Rome, Italy
[5] Univ Cattolica Sacro Cuore, Dipartimento Med Interna & Geriatria, I-00168 Rome, Italy
[6] Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, I-00185 Rome, Italy
[7] Univ Piemonte Orientale, Dipartimento Sci Med, Novara, Italy
关键词
stem cells; myocyte; cardiomyopathy; cytokines; apoptosis;
D O I
10.1002/path.1717
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent studies have documented the presence of stem cells within the myocardium and their role in the repair of ischaemic injury. Nevertheless, the pathogenic role of stem cells in non-ischaemic myocardial diseases, as well as the factors potentially responsible for their activation, is still under debate. The present study demonstrates the presence of an increased number of c-kit positive, MDR-positive, and Sca-1positive stem cells within the myocardium of hereditary delta-SG null hamsters, a spontaneously occurring model of hypertrophic hypertrophic cardiomyopathy. When hamsters are 80 days old, ie at the 'hypertrophic' stage of the disease, but without haemodynamic overload, these cells associate with a multitude of cells co-expressing c-kit, cMet, GATA4, or MEF-2, and proliferating myocytes co-expressing myosin heavy chain, telomerase, ki67 and cyclin B. Furthermore, at the same animal age, the number of myocardial cells co-expressing c-kit and Flk-1 and the number of capillary vessels, is also amplified. In order to identify factors potentially responsible for stem cell activation, the myocardial expression of HGF and cMet and HGF plasma levels were evaluated, demonstrating their increase in 80-day-old delta-SG null hamsters. To demonstrate the possible ability of HGF to induce stem cell differentiation, bone-marrow-derived mesenchymal stem cells were challenged with HGF at the same plasma concentration observed in vivo. HGF induced cMet phosphorylation, and caused loss of stem cell features and overexpression of MEF-2, TEF1, and MHC. Our results demonstrate that stem cell activation occurs within the cardiomyopathic myocardium, very likely to maintain an efficient cardiac architecture. In this context, elevated levels of HGF might play a role in induction of stem cell commitment to the cardiomyocyte lineage and in cardioprotection through its anti-apoptotic action. Consistently, when cytokine levels declined to physiological concentrations, as in 150-day-old cardiomyopathic animals, myocardial apoptosis prevailed, prejudicing cardiac function. Copyright (C) 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley Sons, Ltd.
引用
收藏
页码:397 / 407
页数:11
相关论文
共 45 条
[1]   Selective changes in DNA binding activity of transcription factors in UM-X7.1 cardiomyopathic hamsters [J].
Ambra, R ;
Di Nardo, P ;
Fantini, C ;
Minieri, M ;
Canali, R ;
Natella, F ;
Virgili, F .
LIFE SCIENCES, 2002, 71 (20) :2369-2381
[2]   Phenotypic diversity in hypertrophic cardiomyopathy [J].
Arad, M ;
Seidman, JG ;
Seidman, CE .
HUMAN MOLECULAR GENETICS, 2002, 11 (20) :2499-2506
[3]   Met, metastasis, motility and more [J].
Birchmeier, C ;
Birchmeier, W ;
Gherardi, E ;
Vande Woude, GF .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) :915-925
[4]   HEPATOCYTE GROWTH-FACTOR IS A POTENT ANGIOGENIC FACTOR WHICH STIMULATES ENDOTHELIAL-CELL MOTILITY AND GROWTH [J].
BUSSOLINO, F ;
DIRENZO, MF ;
ZICHE, M ;
BOCCHIETTO, E ;
OLIVERO, M ;
NALDINI, L ;
GAUDINO, G ;
TAMAGNONE, L ;
COFFER, A ;
COMOGLIO, PM .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :629-641
[5]   HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte [J].
Claycomb, WC ;
Lanson, NA ;
Stallworth, BS ;
Egeland, DB ;
Delcarpio, JB ;
Bahinski, A ;
Izzo, NJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (06) :2979-2984
[6]   Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy [J].
Coral-Vazquez, R ;
Cohn, RD ;
Moore, SA ;
Hill, JA ;
Weiss, RM ;
Davisson, RL ;
Straub, V ;
Barresi, R ;
Bansal, D ;
Hrstka, RF ;
Williamson, R ;
Campbell, KP .
CELL, 1999, 98 (04) :465-474
[7]  
DiNardo P, 1997, LAB INVEST, V77, P489
[8]   Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor [J].
Duan, HF ;
Wu, CT ;
Wu, DL ;
Lu, Y ;
Liu, HJ ;
Ha, XQ ;
Zhang, QW ;
Wang, H ;
Jia, XX ;
Wang, LS .
MOLECULAR THERAPY, 2003, 8 (03) :467-474
[9]   Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy [J].
Durbeej, M ;
Sawatzki, SM ;
Barresi, R ;
Schmainda, KM ;
Allamand, V ;
Michele, DE ;
Campbell, KP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (15) :8910-8915
[10]  
FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267